Another group has demonstrated that peptidoglycan contributes to demyelinating autoimmunity by engaging NOD1 and NOD2 in dendritic cells leading to downstream RIPK1 activation (a.k.a. RIP2 and RICK), promoting T-helper 17 (Th17) responses [27]. The gene discussed is RIPK1; the disease is Autoimmunity.